-
Mashup Score: 0
Background: Combined oral contraceptive use is associated with a decreased risk of invasive epithelial ovarian cancer (ovarian cancer). There is suggestive evidence of an inverse association between progestin-only contraceptive use and ovarian cancer risk, but previous studies have been underpowered. Methods: The current study used primary data from 7,977 women with ovarian cancer and 11,820…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Background: Combined oral contraceptive use is associated with a decreased risk of invasive epithelial ovarian cancer (ovarian cancer). There is suggestive evidence of an inverse association between progestin-only contraceptive use and ovarian cancer risk, but previous studies have been underpowered. Methods: The current study used primary data from 7,977 women with ovarian cancer and 11,820…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0FDA approves novel oral contraceptive pill - 3 year(s) ago
The FDA approved a combination drospirenone and estetrol tablet for the prevention of pregnancy, the first combination pill containing naturally occurring estrogen, according to an industry press release.The combination tablet (Nextstellis, Mayne Pharma) is the first and only contraceptive pill containing 3 mg drospirenone and 14.2 mg estetrol, a naturally occurring estrogen produced from a plant
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
.@US_FDA approves, Nextstellis, the first oral #contraceptive to combine drospirenone and estetrol, a naturally occurring steroid hormone, according to Mayne Pharma. https://t.co/5Py8nD0PXX
-
-
Mashup Score: 2Medicaid Payments For Immediate Postpartum Long-Acting Reversible Contraception: Evidence From South Carolina | Health Affairs Journal - 3 year(s) ago
In 2012 South Carolina’s Medicaid program was the first state Medicaid program to separate payment for the immediate postpartum placement of long-acting reversible contraception (intrauterine devices and contraceptive implants) from its global maternity payment. Examining data on all Medicaid-insured South Carolina women giving birth from 2010 to 2014, we found that the new policy achieved its…
Source: www.healthaffairs.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#WomensHealth: In the Feb. issue, @MariaSteenland of @BrownUniversity et al. study the impact of Medicaid in South Carolina separately paying for long-acting reversible #contraceptive. Read their findings on immediate post-partum LARC use in teenagers: https://t.co/Y18rjZLaPB https://t.co/K33nkzBjqg
-
-
Mashup Score: 0
Previous and current use of hormonal contraceptives was associated with a small beneficial effect on asthma exacerbations in reproductive-aged, according to data published in Thorax.Researchers noted that the beneficial effect was relatively small and does not include progestogen-only hormonal contraceptives.
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 4 year(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Previous and current use of hormonal contraceptives was associated with a small beneficial effect on asthma exacerbations in reproductive-aged, according to data published in Thorax.Researchers noted that the beneficial effect was relatively small and does not include progestogen-only hormonal contraceptives.
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Previous and current use of hormonal contraceptives was associated with a small beneficial effect on asthma exacerbations in reproductive-aged, according to data published in Thorax.Researchers noted that the beneficial effect was relatively small and does not include progestogen-only hormonal contraceptives.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Previous and current hormonal #contraceptive use may reduce #asthma exacerbation risk in reproductive-age women, according to data published in @ThoraxBMJ @EndocrineToday @HealioIM https://t.co/YiChXftJGB
-
-
Mashup Score: 3
The Food and Drug Administration has approved Gemmily™, a therapeutic equivalent to Taytulla ® (Allergan), an estrogen/progestin combination oral contraceptive.
Source: Endocrinology AdvisorCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
Early fatherhood is common in the United States (U.S.). The emergency department (ED) plays a disproportionate role in serving patients with unmet reproductive …
Source: SAGE JournalsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
Use of injectable progestin-only #contraceptive, depot-medroxyprogesterone acetate (DMPA), appears to be associated with decreased risk of #OvarianCancer in a duration dependent manner. https://t.co/PMDZ0v9lOK https://t.co/tmKPvmvuwo